Literature DB >> 23241403

Antioxidant enzymes reduce DNA damage and early activation of valvular interstitial cells in aortic valve sclerosis.

Emanuela Branchetti1, Rachana Sainger, Paolo Poggio, Juan B Grau, Jeffrey Patterson-Fortin, Joseph E Bavaria, Michael Chorny, Eric Lai, Robert C Gorman, Robert J Levy, Giovanni Ferrari.   

Abstract

OBJECTIVE: Accumulation of reactive oxygen species (ROS) and remodeling of the microstructure of the cusp characterize aortic valve sclerosis, the early phase of calcific aortic valve disease. These events are associated with activation of valvular interstitial cells (VICs) toward an osteogenic-like phenotype. Because ROS cause DNA damage and transcriptional activation we investigated the relationship between ROS, DNA damage response, and transdifferentiation of VICs. METHODS AND
RESULTS: Human aortic valve cusps and patient-matched VICs were collected from 39 patients both with and without calcific aortic valve disease. VICs were exposed to hydrogen peroxide (0.1-1 mmol/L) after cell transduction with extracellular superoxide dismutase/catalase adenoviruses and characterized for DNA-damage response, osteogenic transdifferentiation, and calcification. ROS induce relocalization of phosphorylated γH2AX, MRE11, and XRCC1 proteins with expression of osteogenic signaling molecule RUNX2 via AKT. We report a sustained activation of γH2AX in aortic valve sclerosis-derived VICs suggesting their impaired ability to repair DNA damage. Adenovirus superoxide dismutase/catalase transduction decreases ROS-induced DNA damage and VIC transdifferentiation in aortic valve sclerosis-derived cells. Finally, adenoviral transduction with catalase reverts ROS-mediated calcification and cellular transdifferentiation.
CONCLUSIONS: We conclude that the ROS-induced DNA damage response is dysfunctional in early asymptomatic stages of calcific aortic valve disease. We unveiled an association among ROS, DNA-damage response, and cellular transdifferentiation, reversible by antioxidant enzymes delivery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23241403      PMCID: PMC4080420          DOI: 10.1161/ATVBAHA.112.300177

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  59 in total

Review 1.  Aortic stenosis: clinical aspects of diagnosis and management, with 10 illustrative case reports from a 25-year experience.

Authors:  Christopher E Kurtz; Catherine M Otto
Journal:  Medicine (Baltimore)       Date:  2010-11       Impact factor: 1.889

Review 2.  Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

Authors:  Nalini M Rajamannan; Frank J Evans; Elena Aikawa; K Jane Grande-Allen; Linda L Demer; Donald D Heistad; Craig A Simmons; Kristyn S Masters; Patrick Mathieu; Kevin D O'Brien; Frederick J Schoen; Dwight A Towler; Ajit P Yoganathan; Catherine M Otto
Journal:  Circulation       Date:  2011-10-18       Impact factor: 29.690

Review 3.  Assembly and function of DNA double-strand break repair foci in mammalian cells.

Authors:  Simon Bekker-Jensen; Niels Mailand
Journal:  DNA Repair (Amst)       Date:  2010-10-28

4.  Validation of plasma biomarkers in degenerative calcific aortic stenosis.

Authors:  Giovanni Ferrari; Rachana Sainger; Erik Beckmann; Gianluca Keller; Pey-Jen Yu; Maria Cristina Monti; Aubrey C Galloway; Richard L Weiss; William Vernick; Juan B Grau
Journal:  J Surg Res       Date:  2010-05-06       Impact factor: 2.192

Review 5.  Insights into the use of biomarkers in calcific aortic valve disease.

Authors:  Erik Beckmann; Juan B Grau; Rachana Sainger; Paolo Poggio; Giovanni Ferrari
Journal:  J Heart Valve Dis       Date:  2010-07

Review 6.  Regulatory mechanisms in vascular calcification.

Authors:  Andrew P Sage; Yin Tintut; Linda L Demer
Journal:  Nat Rev Cardiol       Date:  2010-07-27       Impact factor: 32.419

Review 7.  Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential.

Authors:  Ines Batinić-Haberle; Júlio S Rebouças; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2010-09-15       Impact factor: 8.401

Review 8.  Immunofluorescence imaging of DNA damage response proteins: optimizing protocols for super-resolution microscopy.

Authors:  Brian T Bennett; Jörg Bewersdorf; Kendall L Knight
Journal:  Methods       Date:  2009-02-24       Impact factor: 3.608

Review 9.  The DNA damage response: making it safe to play with knives.

Authors:  Alberto Ciccia; Stephen J Elledge
Journal:  Mol Cell       Date:  2010-10-22       Impact factor: 17.970

10.  Cell biology beyond the cell.

Authors:  Priya Prakash Budde; Tom Misteli
Journal:  J Cell Biol       Date:  2010-07-12       Impact factor: 10.539

View more
  46 in total

Review 1.  Fibrocalcific aortic valve disease: opportunity to understand disease mechanisms using mouse models.

Authors:  Robert M Weiss; Jordan D Miller; Donald D Heistad
Journal:  Circ Res       Date:  2013-07-05       Impact factor: 17.367

Review 2.  Carbonyl stress in aging process: role of vitamins and phytochemicals as redox regulators.

Authors:  Volkan Ergin; Reza Ebrahimi Hariry; Cimen Karasu
Journal:  Aging Dis       Date:  2013-10-01       Impact factor: 6.745

3.  Comparative genome-wide transcriptional analysis of human left and right internal mammary arteries.

Authors:  Giovanni Ferrari; John Quackenbush; John Strobeck; Lan Hu; Christopher K Johnson; Andrew Mak; Richard E Shaw; Kathleen Sayles; Mariano E Brizzio; Alex Zapolanski; Juan B Grau
Journal:  Genomics       Date:  2014-05-20       Impact factor: 5.736

4.  Oxidized HDL, as a Novel Biomarker for Calcific Aortic Valve Disease, Promotes the Calcification of Aortic Valve Interstitial Cells.

Authors:  Jia Teng Sun; Yuan Yuan Chen; Jing Yan Mao; Yan Ping Wang; Ya Fen Chen; Xiang Hu; Ke Yang; Yan Liu
Journal:  J Cardiovasc Transl Res       Date:  2019-07-31       Impact factor: 4.132

5.  The negative effect of magnetic nanoparticles with ascorbic acid on peritoneal macrophages.

Authors:  Klára Jiráková; Maksym Moskvin; Lucia Machová Urdzíková; Pavel Rössner; Fatima Elzeinová; Milada Chudíčková; Daniel Jirák; Natalia Ziolkowska; Daniel Horák; Šárka Kubinová; Pavla Jendelová
Journal:  Neurochem Res       Date:  2019-04-03       Impact factor: 3.996

6.  Serotonin receptor 2B signaling with interstitial cell activation and leaflet remodeling in degenerative mitral regurgitation.

Authors:  Kathryn H Driesbaugh; Emanuela Branchetti; Juan B Grau; Samuel J Keeney; Kimberly Glass; Mark A Oyama; Nancy Rioux; Salma Ayoub; Michael S Sacks; John Quackenbush; Robert J Levy; Giovanni Ferrari
Journal:  J Mol Cell Cardiol       Date:  2017-12-30       Impact factor: 5.000

Review 7.  Adaptive immune cells in calcific aortic valve disease.

Authors:  Michael A Raddatz; Meena S Madhur; W David Merryman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-03       Impact factor: 4.733

Review 8.  Shear-Sensitive Genes in Aortic Valve Endothelium.

Authors:  Joan Fernández Esmerats; Jack Heath; Hanjoong Jo
Journal:  Antioxid Redox Signal       Date:  2016-01-21       Impact factor: 8.401

9.  Noggin attenuates the osteogenic activation of human valve interstitial cells in aortic valve sclerosis.

Authors:  Paolo Poggio; Rachana Sainger; Emanuela Branchetti; Juan B Grau; Eric K Lai; Robert C Gorman; Michael S Sacks; Alessandro Parolari; Joseph E Bavaria; Giovanni Ferrari
Journal:  Cardiovasc Res       Date:  2013-03-12       Impact factor: 10.787

10.  Heart valve disease: the role of calcidiol deficiency, elevated parathyroid hormone levels and oxidative stress in mitral and aortic valve insufficiency.

Authors:  Esin Eren; Hamit Yasar Ellidag; Yesim Cekin; Raif Umut Ayoglu; Ali Osman Sekercioglu; Necat Yılmaz
Journal:  Redox Rep       Date:  2013-11-26       Impact factor: 4.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.